Streetbeat News

Stock Prices

RACE

Ferrari projects its adjusted earnings per share (EPS) to be equal to or greater than €7.50 by 2024, with net revenues expected to exceed €6.4 billion.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:17 am

HON

Honeywell Intl's shares dropped following mixed Q4 earnings and a disappointing revenue outlook for FY24.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:15 am

SWK

Stanley Black & Decker's shares dropped following mixed Q4 earnings and a disappointing FY24 EPS forecast.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:12 am

LPG

Dorian LPG reported Q3 adjusted EPS of $2.62, surpassing the $1.80 estimate, and sales of $163.06M, exceeding the $159.71M estimate. This represents a 103.1% increase in earnings and a 57.82% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:11 am

AXR

PFBX

RCUS

$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying. Notable insider purchases were made in Arcus Biosciences, Peoples Financial, and AMREP, indicating confidence in these companies. Gilead Sciences Inc acquired shares of Arcus Biosciences for $320 million. Peoples Financial CEO bought shares worth $81,568. AMREP saw a purchase of $891,020 by Rainey Lancaster.

Portfolio Pulse from Avi Kapoor

February 01, 2024 | 11:09 am

REVB

Revelation Biosciences has announced the pricing of its public offering at $4.53 per share, including 1.365 million shares and warrants to purchase up to 2.730 million shares, aiming for gross proceeds of $6.2 million.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:07 am

HON

Honeywell International Inc. (HON) reported Q4 adjusted earnings per share (EPS) of $2.60, slightly above the consensus estimate of $2.59, marking a 3.17% year-over-year increase. However, its quarterly sales of $9.44 billion fell short of the expected $9.70 billion, a 2.68% miss, though it represents a 2.77% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:04 am

FCFS

FirstCash Hldgs (NASDAQ:FCFS) reported Q4 adjusted EPS of $2.04, surpassing the $1.79 estimate, marking a 23.64% year-over-year increase. However, their sales of $852.13M slightly missed the $853.35M estimate, though still representing a 12.54% increase from the previous year.

Portfolio Pulse from mahesh@benzinga.com

February 01, 2024 | 11:04 am

RVTY

Revvity forecasts its 2024 revenue to be between $2.79B-$2.85B and adjusted EPS to be between $4.55-$4.75, surpassing the consensus estimates of $2.77B in revenue and $4.60 in adjusted EPS.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:04 am

RVTY

Revvity (NYSE:RVTY) reported Q4 adjusted EPS of $1.25, surpassing the $1.16 estimate, with sales of $695.90M also beating the $677.94M estimate. However, both earnings and sales saw a decrease compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:02 am